ES8405638A1 - Procedimiento para la obtencion de una suspension homogeneizada de fases lamelares lipidicas hidratadas en un liquido - Google Patents
Procedimiento para la obtencion de una suspension homogeneizada de fases lamelares lipidicas hidratadas en un liquidoInfo
- Publication number
- ES8405638A1 ES8405638A1 ES526498A ES526498A ES8405638A1 ES 8405638 A1 ES8405638 A1 ES 8405638A1 ES 526498 A ES526498 A ES 526498A ES 526498 A ES526498 A ES 526498A ES 8405638 A1 ES8405638 A1 ES 8405638A1
- Authority
- ES
- Spain
- Prior art keywords
- dispersions
- lipidic lamellar
- dispersion
- homogenising
- lamellar phases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
- B01F25/40—Static mixers
- B01F25/44—Mixers in which the components are pressed through slits
- B01F25/441—Mixers in which the components are pressed through slits characterised by the configuration of the surfaces forming the slits
- B01F25/4413—Mixers in which the components are pressed through slits characterised by the configuration of the surfaces forming the slits the slits being formed between opposed conical or cylindrical surfaces
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
- B01F25/40—Static mixers
- B01F25/44—Mixers in which the components are pressed through slits
- B01F25/442—Mixers in which the components are pressed through slits characterised by the relative position of the surfaces during operation
- B01F25/4422—Mixers in which the components are pressed through slits characterised by the relative position of the surfaces during operation the surfaces being maintained in a fixed but adjustable position, spaced from each other, therefore allowing the slit spacing to be varied
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
- B01F25/40—Static mixers
- B01F25/45—Mixers in which the materials to be mixed are pressed together through orifices or interstitial spaces, e.g. between beads
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S516/00—Colloid systems and wetting agents; subcombinations thereof; processes of
- Y10S516/924—Significant dispersive or manipulative operation or step in making or stabilizing colloid system
- Y10S516/929—Specified combination of agitation steps, e.g. mixing to make subcombination composition followed by homogenization
- Y10S516/93—Low shear followed by high shear
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/778—Nanostructure within specified host or matrix material, e.g. nanocomposite films
- Y10S977/783—Organic host/matrix, e.g. lipid
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/84—Manufacture, treatment, or detection of nanostructure
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/926—Topical chemical, e.g. cosmetic or sunscreen
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Birds (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Colloid Chemistry (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Polymerisation Methods In General (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Abstract
PROCEDIMIENTO PARA LA OBTENCION DE UNA SUSPENSION HOMOGENEIZADA DE FASES LAMELARES LIPIDICAS HIDRATADAS EN UN LIQUIDO, TAL COMO UNA SUSPENSION DE LIPOSOMAS.CONSISTE EN DISPERSAR UNA FASE LIPIDICA O UNA FASE LAMELAR LIPIDICA QUE CONTIENE UNO O VARIOS LIPIDOS ANFIFILOS Y UNO O VARIOS COMPONENTES DE CARACTER HIDROFOBO, EN UN LIQUIDO, Y EN HOMOGENEIZAR DESPUES DICHA DISPERSION HACIENDOLA PASAR A TRAVES DE UN PASO DE POCA ANCHURA, DEFINIDO ENTRE LAS PAREDES DE UN ORIFICIO Y LOS BORDES DE UN ELEMENTO OBTURADOR DISPUESTO DE MANERA REGULABLE EN LA SECCION DEDICHO ORIFICIO, EN OPOSICION AL FLUJO DE DICHA DISPERSION.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8217311A FR2534487B1 (fr) | 1982-10-15 | 1982-10-15 | Procede d'homogeneisation de dispersions de phases lamellaires lipidiques hydratees, et suspensions obtenues par ce procede |
Publications (2)
Publication Number | Publication Date |
---|---|
ES526498A0 ES526498A0 (es) | 1984-06-16 |
ES8405638A1 true ES8405638A1 (es) | 1984-06-16 |
Family
ID=9278316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES526498A Expired ES8405638A1 (es) | 1982-10-15 | 1983-10-14 | Procedimiento para la obtencion de una suspension homogeneizada de fases lamelares lipidicas hidratadas en un liquido |
Country Status (12)
Country | Link |
---|---|
US (1) | US4621023A (es) |
EP (1) | EP0107559B2 (es) |
JP (1) | JPS5989620A (es) |
AT (1) | ATE27909T1 (es) |
CA (1) | CA1228779A (es) |
DE (2) | DE107559T1 (es) |
DK (1) | DK159194C (es) |
ES (1) | ES8405638A1 (es) |
FR (1) | FR2534487B1 (es) |
GR (1) | GR79616B (es) |
HK (1) | HK49988A (es) |
IL (1) | IL69911A0 (es) |
Families Citing this family (110)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4753788A (en) * | 1985-01-31 | 1988-06-28 | Vestar Research Inc. | Method for preparing small vesicles using microemulsification |
FR2591105B1 (fr) | 1985-12-11 | 1989-03-24 | Moet Hennessy Rech | Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide. |
AU598002B2 (en) * | 1986-07-15 | 1990-06-14 | Cilag Ltd. | Method of preparing single bilayered liposomes |
AU604288B2 (en) * | 1987-01-26 | 1990-12-13 | Vestar, Inc. | Phospholipid delivery vehicle for aqueous-insoluble active ingredients |
JPS63209746A (ja) * | 1987-02-27 | 1988-08-31 | Terumo Corp | リポソ−ムの製法 |
JP2599390B2 (ja) * | 1987-06-25 | 1997-04-09 | 第一製薬株式会社 | 安定なリポソーム水分散液 |
FR2623716B1 (fr) * | 1987-11-27 | 1991-04-05 | Lvmh Rech | Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant de la tyrosine ou un derive de tyrosine et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite pigmentante, l'incorporant |
US5290562A (en) * | 1987-11-27 | 1994-03-01 | L V M H Recherche | Compositions and methods employing liposomes including tyrosine or a tyrosine derivative |
CH675967A5 (es) * | 1987-12-09 | 1990-11-30 | Induchem Ag | |
US4895452A (en) * | 1988-03-03 | 1990-01-23 | Micro-Pak, Inc. | Method and apparatus for producing lipid vesicles |
DE3905354C2 (de) * | 1989-02-22 | 2000-02-10 | Reinhold A Brunke | Vorrichtung zum Zerkleinern von Liposomen |
FR2649335B1 (fr) * | 1989-07-05 | 1991-09-20 | Texinfine Sa | Procede et dispositif de production directe de liposomes |
WO1991004014A1 (en) * | 1989-09-21 | 1991-04-04 | Synergen, Inc. | Method for transporting compositions across the blood brain barrier |
US5656211A (en) | 1989-12-22 | 1997-08-12 | Imarx Pharmaceutical Corp. | Apparatus and method for making gas-filled vesicles of optimal size |
US5305757A (en) | 1989-12-22 | 1994-04-26 | Unger Evan C | Gas filled liposomes and their use as ultrasonic contrast agents |
US20020150539A1 (en) | 1989-12-22 | 2002-10-17 | Unger Evan C. | Ultrasound imaging and treatment |
US5469854A (en) | 1989-12-22 | 1995-11-28 | Imarx Pharmaceutical Corp. | Methods of preparing gas-filled liposomes |
US5922304A (en) | 1989-12-22 | 1999-07-13 | Imarx Pharmaceutical Corp. | Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents |
US5585112A (en) | 1989-12-22 | 1996-12-17 | Imarx Pharmaceutical Corp. | Method of preparing gas and gaseous precursor-filled microspheres |
US6146657A (en) | 1989-12-22 | 2000-11-14 | Imarx Pharmaceutical Corp. | Gas-filled lipid spheres for use in diagnostic and therapeutic applications |
US5733572A (en) | 1989-12-22 | 1998-03-31 | Imarx Pharmaceutical Corp. | Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles |
US5773024A (en) | 1989-12-22 | 1998-06-30 | Imarx Pharmaceutical Corp. | Container with multi-phase composition for use in diagnostic and therapeutic applications |
US5705187A (en) | 1989-12-22 | 1998-01-06 | Imarx Pharmaceutical Corp. | Compositions of lipids and stabilizing materials |
US6551576B1 (en) | 1989-12-22 | 2003-04-22 | Bristol-Myers Squibb Medical Imaging, Inc. | Container with multi-phase composition for use in diagnostic and therapeutic applications |
US5352435A (en) * | 1989-12-22 | 1994-10-04 | Unger Evan C | Ionophore containing liposomes for ultrasound imaging |
US5580575A (en) * | 1989-12-22 | 1996-12-03 | Imarx Pharmaceutical Corp. | Therapeutic drug delivery systems |
US5088499A (en) * | 1989-12-22 | 1992-02-18 | Unger Evan C | Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same |
US6001335A (en) | 1989-12-22 | 1999-12-14 | Imarx Pharmaceutical Corp. | Contrasting agents for ultrasonic imaging and methods for preparing the same |
US5334381A (en) * | 1989-12-22 | 1994-08-02 | Unger Evan C | Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same |
US6088613A (en) | 1989-12-22 | 2000-07-11 | Imarx Pharmaceutical Corp. | Method of magnetic resonance focused surgical and therapeutic ultrasound |
US5542935A (en) * | 1989-12-22 | 1996-08-06 | Imarx Pharmaceutical Corp. | Therapeutic delivery systems related applications |
US5776429A (en) | 1989-12-22 | 1998-07-07 | Imarx Pharmaceutical Corp. | Method of preparing gas-filled microspheres using a lyophilized lipids |
EP0461333B1 (en) * | 1990-06-11 | 1995-03-29 | Idi Farmaceutici S.P.A. | Phospholipidic liposomes containing active principles and a process for the production thereof |
JPH04107319U (ja) * | 1991-02-26 | 1992-09-16 | 大日本プラスチツクス株式会社 | 外装材取付構造 |
FR2673840A1 (fr) * | 1991-03-14 | 1992-09-18 | Lvmh Rech | Composition cosmetique ou pharmaceutique, notamment dermatologique, contenant de l'oxyacanthine, en particulier destinee a stimuler la pousse des cheveux ou a retarder leur chute. |
US5205290A (en) | 1991-04-05 | 1993-04-27 | Unger Evan C | Low density microspheres and their use as contrast agents for computed tomography |
US5874062A (en) | 1991-04-05 | 1999-02-23 | Imarx Pharmaceutical Corp. | Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents |
WO1993000156A1 (en) * | 1991-06-29 | 1993-01-07 | Miyazaki-Ken | Monodisperse single and double emulsions and production thereof |
FR2695035A1 (fr) * | 1992-08-25 | 1994-03-04 | Lvmh Rech Gie | Utilisation d'un ecdystéroïde pour la préparation de compositions cosmétiques ou dermatologiques destinées notamment à renforcer la fonction protectrice de la peau, et compositions ainsi obtenues. |
WO1994012155A1 (en) * | 1992-12-02 | 1994-06-09 | Vestar, Inc. | Antibiotic formulation and process |
US5958449A (en) | 1992-12-02 | 1999-09-28 | Nexstar Pharmaceuticals, Inc. | Antibiotic formulation and use for bacterial infections |
FR2699081B1 (fr) | 1992-12-11 | 1995-04-07 | Lvmh Rech | Utilisation d'un extrait de Simaba pour l'atténuation des taches pigmentaires cutanées ou pour renforcer la fonction protectrice de la peau, ou pour la préparation d'un milieu de culture de cellules de peau, et composition ainsi obtenue. |
FR2699080B1 (fr) | 1992-12-11 | 1995-04-07 | Lvmh Rech | Utilisation d'un extrait de Simarouba pour l'atténuation des taches pigmentaires cutanées ou pour renforcer la fonction protectrice de la peau, ou pour la préparation d'un milieu de culture de cellules de peau, et composition ainsi obtenue. |
DE4309971A1 (de) * | 1993-03-26 | 1994-09-29 | Bayer Ag | Imprägnierungsemulsion für mineralische Baustoffe |
US5759571A (en) * | 1993-05-11 | 1998-06-02 | Nexstar Pharmaceuticals, Inc. | Antibiotic formulation and use for drug resistant infections |
US5492648A (en) * | 1993-07-02 | 1996-02-20 | Lau; John R. | Organic oil stabilization techniques |
US7083572B2 (en) | 1993-11-30 | 2006-08-01 | Bristol-Myers Squibb Medical Imaging, Inc. | Therapeutic delivery systems |
US5736121A (en) | 1994-05-23 | 1998-04-07 | Imarx Pharmaceutical Corp. | Stabilized homogenous suspensions as computed tomography contrast agents |
US5843334A (en) * | 1994-06-20 | 1998-12-01 | Nippon Shinyaku Co., Ltd. | Method of producing emulsions and an emulsification apparatus |
JP2976526B2 (ja) * | 1994-06-20 | 1999-11-10 | 日本新薬株式会社 | 乳剤の製法及び乳化機 |
US7196055B2 (en) | 1994-08-31 | 2007-03-27 | Trustees Of Boston University | Inhibition of apoptosis in keratinocytes by a ligand of p75 nerve growth factor receptor |
US6867179B1 (en) | 1994-08-31 | 2005-03-15 | Trustees Of Boston University | Methods of inducing hair growth and coloration |
US6743779B1 (en) | 1994-11-29 | 2004-06-01 | Imarx Pharmaceutical Corp. | Methods for delivering compounds into a cell |
US5830430A (en) | 1995-02-21 | 1998-11-03 | Imarx Pharmaceutical Corp. | Cationic lipids and the use thereof |
US7094766B1 (en) | 1995-06-06 | 2006-08-22 | Trustees Of Boston University | Use of locally applied DNA fragments |
US6147056A (en) * | 1995-06-06 | 2000-11-14 | Trustees Of Boston University | Use of locally applied DNA fragments |
US20030032610A1 (en) * | 1996-06-03 | 2003-02-13 | Gilchrest Barbara A. | Method to inhibit cell growth using oligonucleotides |
US5997898A (en) | 1995-06-06 | 1999-12-07 | Imarx Pharmaceutical Corp. | Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery |
US6139819A (en) | 1995-06-07 | 2000-10-31 | Imarx Pharmaceutical Corp. | Targeted contrast agents for diagnostic and therapeutic use |
US6033645A (en) | 1996-06-19 | 2000-03-07 | Unger; Evan C. | Methods for diagnostic imaging by regulating the administration rate of a contrast agent |
US6231834B1 (en) | 1995-06-07 | 2001-05-15 | Imarx Pharmaceutical Corp. | Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same |
US6521211B1 (en) | 1995-06-07 | 2003-02-18 | Bristol-Myers Squibb Medical Imaging, Inc. | Methods of imaging and treatment with targeted compositions |
NL1001380C2 (nl) * | 1995-10-09 | 1997-04-11 | Fuji Photo Film Bv | Methode voor het dispergeren van een geëmulgeerd materiaal van het olie-druppeltype in een vloeistoftoevoersysteem en bekledingsmethode waarbij van een dergelijke dispergeermethode gebruik wordt gemaakt. |
AU723585B2 (en) * | 1996-03-28 | 2000-08-31 | Trustees Of Boston University | Methods of modulating melanin synthesis |
JP2001507207A (ja) | 1996-05-01 | 2001-06-05 | イマアーレクス・フアーマシユーチカル・コーポレーシヨン | 化合物を細胞に送達する方法 |
US6414139B1 (en) | 1996-09-03 | 2002-07-02 | Imarx Therapeutics, Inc. | Silicon amphiphilic compounds and the use thereof |
US5846517A (en) | 1996-09-11 | 1998-12-08 | Imarx Pharmaceutical Corp. | Methods for diagnostic imaging using a renal contrast agent and a vasodilator |
ES2189974T3 (es) | 1996-09-11 | 2003-07-16 | Imarx Pharmaceutical Corp | Procedimientos mejorados para la obtencion de imagenes de diagnostico usando un agente de contraste y un vasodilatador. |
ES2134130B1 (es) * | 1997-02-05 | 2000-04-16 | Inst Cientifico Tecnol Navarra | Procedimiento y aparato para la produccion de vectores no biologicos de transporte de sustancias por inyeccion coaxial turbulenta. |
US6143276A (en) | 1997-03-21 | 2000-11-07 | Imarx Pharmaceutical Corp. | Methods for delivering bioactive agents to regions of elevated temperatures |
US6537246B1 (en) | 1997-06-18 | 2003-03-25 | Imarx Therapeutics, Inc. | Oxygen delivery agents and uses for the same |
US6120751A (en) | 1997-03-21 | 2000-09-19 | Imarx Pharmaceutical Corp. | Charged lipids and uses for the same |
US6090800A (en) | 1997-05-06 | 2000-07-18 | Imarx Pharmaceutical Corp. | Lipid soluble steroid prodrugs |
US7452551B1 (en) | 2000-10-30 | 2008-11-18 | Imarx Therapeutics, Inc. | Targeted compositions for diagnostic and therapeutic use |
US6416740B1 (en) | 1997-05-13 | 2002-07-09 | Bristol-Myers Squibb Medical Imaging, Inc. | Acoustically active drug delivery systems |
US6548047B1 (en) | 1997-09-15 | 2003-04-15 | Bristol-Myers Squibb Medical Imaging, Inc. | Thermal preactivation of gaseous precursor filled compositions |
US6123923A (en) | 1997-12-18 | 2000-09-26 | Imarx Pharmaceutical Corp. | Optoacoustic contrast agents and methods for their use |
US20010003580A1 (en) | 1998-01-14 | 2001-06-14 | Poh K. Hui | Preparation of a lipid blend and a phospholipid suspension containing the lipid blend |
ES2216423T3 (es) | 1998-12-07 | 2004-10-16 | Dsm Ip Assets B.V. | Metodo y dispositivo para mezclar o dispersar liquidos. |
EP2363133A1 (en) * | 2000-03-31 | 2011-09-07 | Trustees of Boston University | Composition comprising DNA fragments and medical and cosmetic uses thereof |
US20030212046A1 (en) * | 2002-05-07 | 2003-11-13 | Kapac, Llc | Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs |
US20060093661A1 (en) | 2002-05-07 | 2006-05-04 | Kapac, Llc | Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs |
EA003388B1 (ru) * | 2002-07-18 | 2003-04-24 | Ооо "Био-3" | Способ получения вододисперсионных препаратов жирорастворимых витаминов и антиоксидантов |
US20060269924A1 (en) * | 2003-04-11 | 2006-11-30 | Trustees Of Boston University | Modulation of telomere-initiated cell signaling |
MXPA06005593A (es) * | 2003-11-20 | 2007-02-12 | Zomanex Llc | Metodos y formulaciones para el tratamiento de condiciones medicas relacionadas con la dihidrotestosterona elevada. |
FR2864539B1 (fr) * | 2003-12-30 | 2012-10-26 | Lvmh Rech | Oligonucleotide et son utilisation pour moduler l'expression de la proteine-kinase c isoforme beta-1 comme agent de depigmentation cutanee |
TR200606490T1 (tr) | 2004-05-19 | 2007-01-22 | Trustees Of Boston University | WRN aracılığında telomerin başlattığı hücre sinyallerinin modülasyonu. |
ATE431740T1 (de) * | 2004-12-22 | 2009-06-15 | Merck Serono Sa | Kombinationstherapie gegen multiple sklerose |
US8007790B2 (en) | 2006-04-03 | 2011-08-30 | Stowers Institute For Medical Research | Methods for treating polycystic kidney disease (PKD) or other cyst forming diseases |
US20080124387A1 (en) | 2006-11-27 | 2008-05-29 | Kapac, Llc | Methods and formulations for enhancing the absorption and decreasing the absorption variability of orally administered drugs, vitamins and nutrients |
US20080207711A1 (en) * | 2007-02-28 | 2008-08-28 | Rong Li | Method for treating an ID2-related disorder |
CH715456B1 (de) | 2007-04-27 | 2020-04-30 | Mibelle Ag | Kosmetisches Produkt zur topischen Anwendung für den Schutz und die Erneuerung von Hautstammzellen, welches sich von dedifferenzierten Pflanzenzellen ableitet. |
US20090088393A1 (en) * | 2007-09-28 | 2009-04-02 | Zomanex, Llc | Methods and formulations for converting intravenous and injectable drugs into oral dosage forms |
NZ591955A (en) | 2007-10-16 | 2011-10-28 | Repros Therapeutics Inc | Trans-clomiphene for diabetes mellitus type 2 |
US8101606B2 (en) * | 2007-11-12 | 2012-01-24 | Washington University | Neurofibromin pathway modulators |
TWI539953B (zh) | 2008-04-28 | 2016-07-01 | 瑞波若斯治療學公司 | 用於治療乳癌之組成物和方法 |
TWI477276B (zh) | 2008-04-28 | 2015-03-21 | Repros Therapeutics Inc | 抗黃體素給藥方案 |
CA2675704C (en) | 2009-08-18 | 2010-05-25 | The Procter & Gamble Company | A method of making a fabric softening composition using a dynamic orifice with a valve in different positions |
US8173589B2 (en) * | 2010-03-18 | 2012-05-08 | The Procter & Gamble Company | Low energy methods of making pearlescent fabric softener compositions |
JP5894143B2 (ja) | 2010-03-22 | 2016-03-23 | リプロス セラピューティクス インコーポレイテッド | 抗黄体ホルモンの無毒送達のための組成物および方法 |
UA113283C2 (xx) | 2010-12-23 | 2017-01-10 | 19-норстероїди і їх застосування для лікування прогестеронзалежних станів | |
US20130084326A1 (en) * | 2011-10-03 | 2013-04-04 | Bruce Howe | Liposomes for the oral delivery of therapeutic agents |
NZ702467A (en) | 2012-05-31 | 2016-07-29 | Repros Therapeutics Inc | Formulations and methods for vaginal delivery of antiprogestins |
CN104755087A (zh) | 2012-11-02 | 2015-07-01 | 利普生物药剂公司 | 治疗孕酮依赖性病况的方法和组合物 |
EP3124609A1 (en) | 2015-07-29 | 2017-02-01 | IFOM Fondazione Istituto Firc di Oncologia Molecolare | Therapeutics oligonucleotides |
EP3329004B1 (en) | 2015-07-29 | 2020-01-15 | IFOM Fondazione Istituto Firc di Oncologia Molecolare | Therapeutic oligonucleotides |
WO2019238862A1 (en) * | 2018-06-14 | 2019-12-19 | Tetra Laval Holdings & Finance S.A. | Homogenizer for liquid food and method of homogenizing |
US20210300939A1 (en) | 2018-07-23 | 2021-09-30 | Signalrx Pharmaceuticals, Inc. | Single Molecule Compounds Providing Multi-Target Inhibition of BTK and Other Proteins and Methods of Use Thereof |
WO2020055946A1 (en) | 2018-09-12 | 2020-03-19 | The Broad Institute, Inc. | Targeting egln1 in cancer |
EP4050002A1 (en) | 2021-02-26 | 2022-08-31 | First Health Pharmaceuticals B.V. | Anti-proliferative agents |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH366518A (de) * | 1959-01-15 | 1963-01-15 | Lendi Wilhelm | Homogenisiervorrichtung |
JPS5186117A (en) * | 1975-01-27 | 1976-07-28 | Tanabe Seiyaku Co | Johoseibiryushiseizainoseiho |
US4235871A (en) * | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
US4263428A (en) * | 1978-03-24 | 1981-04-21 | The Regents Of The University Of California | Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same |
JPS55140359U (es) * | 1979-03-29 | 1980-10-07 |
-
1982
- 1982-10-15 FR FR8217311A patent/FR2534487B1/fr not_active Expired
-
1983
- 1983-10-05 IL IL69911A patent/IL69911A0/xx unknown
- 1983-10-06 EP EP83401954A patent/EP0107559B2/fr not_active Expired - Lifetime
- 1983-10-06 DE DE198383401954T patent/DE107559T1/de active Pending
- 1983-10-06 AT AT83401954T patent/ATE27909T1/de not_active IP Right Cessation
- 1983-10-06 DE DE8383401954T patent/DE3372174D1/de not_active Expired
- 1983-10-07 CA CA000438664A patent/CA1228779A/en not_active Expired
- 1983-10-07 GR GR72692A patent/GR79616B/el unknown
- 1983-10-13 US US06/541,426 patent/US4621023A/en not_active Expired - Lifetime
- 1983-10-14 DK DK475483A patent/DK159194C/da not_active IP Right Cessation
- 1983-10-14 ES ES526498A patent/ES8405638A1/es not_active Expired
- 1983-10-15 JP JP58193331A patent/JPS5989620A/ja active Granted
-
1988
- 1988-07-07 HK HK499/88A patent/HK49988A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JPH0131414B2 (es) | 1989-06-26 |
DE107559T1 (de) | 1985-04-25 |
DE3372174D1 (en) | 1987-07-30 |
ES526498A0 (es) | 1984-06-16 |
DK475483A (da) | 1984-04-16 |
EP0107559B2 (fr) | 1997-12-17 |
EP0107559A1 (fr) | 1984-05-02 |
DK159194B (da) | 1990-09-17 |
JPS5989620A (ja) | 1984-05-23 |
CA1228779A (en) | 1987-11-03 |
DK475483D0 (da) | 1983-10-14 |
IL69911A0 (en) | 1984-01-31 |
EP0107559B1 (fr) | 1987-06-24 |
ATE27909T1 (de) | 1987-07-15 |
DK159194C (da) | 1991-02-25 |
FR2534487A1 (fr) | 1984-04-20 |
HK49988A (en) | 1988-07-15 |
GR79616B (es) | 1984-10-31 |
FR2534487B1 (fr) | 1988-06-10 |
US4621023A (en) | 1986-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8405638A1 (es) | Procedimiento para la obtencion de una suspension homogeneizada de fases lamelares lipidicas hidratadas en un liquido | |
AU3703095A (en) | Method and apparatus for diffusive transfer between immiscible fluids | |
NO954756D0 (no) | Fremgangsmåte og apparatur for fremstilling av liposomer | |
IL108583A (en) | Galactomannan emulsions and comestible products containing the same | |
DE69528077T2 (de) | Verfahren zur Herstellung von Liposomen, die hydrophobische Artzneistoffe enthalten | |
GR77128B (es) | ||
IL108738A0 (en) | New multiple emulsions, their preparation, their use in the preparation of cosmetic compositions and these cosmetic compositions | |
KR950007831A (ko) | 세라미드와 리놀렌산을 혼합한 신규 화장제 및 피부학적 조성물, 및 그의 제법 | |
AU1723395A (en) | Oil-in-water emulsions | |
ES8300499A1 (es) | "un procedimiento para obtener vesiculas". | |
CA2263736A1 (en) | Food product dressings and methods for preparing food product dressings | |
WO1993013675A3 (en) | Process for making spreads and spreads obtainable by the process | |
GB2042219B (en) | Apparatus for regulating the delivery flow and for limiting the delivery pressure from an adjustable pump | |
GR3018064T3 (en) | Aqueous phospholipid vesicle dispersion, process for its manufacture and use thereof. | |
EP0399147A3 (de) | Vorrichtung zum Beschichten einer um eine Gegenwalze geführten Materialbahn | |
GB9717476D0 (en) | Process | |
DE69524581D1 (de) | Retinal enthaltendes arzneimittel | |
CA1008108A (en) | Method for establishing core-flow in water-in-oil emulsions or dispersions | |
IT1096066B (it) | Valvola erogatrice e miscelatrice particolarmente per recipienti contenenti due prodotti in pressione materialmente separati tra loro | |
Sherman | Factors influencing the instrumental and sensory evaluation of food emulsions | |
GB9224010D0 (en) | Composition and method | |
FI77778B (fi) | Kosmetiskt medel innehaollande en dubbelemulsion och foerfarande foer dess framstaellning. | |
ES8307949A1 (es) | Dispositivo para convertir en espuma un bano de tratamiento en una camara de mezclado. | |
SU1729006A1 (ru) | Способ производства майонеза | |
DE1797157U (de) | Verpackungskartonage fuer koerniges schuettgut mit ausflussklappe. |